Company / Assets per Share
Arrowhead Pharmaceuticals Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$11.14
FY2025
5-year range
$6.63 / $11.14
FY2021-FY2025
Trend
+4.9%
vs FY2024
Sector context
#87 of 210
Health Care
What the data says
At $11.14, Arrowhead Pharmaceuticals's assets per share ranks #87 of 210 in the Health Care sector. Assets per Share has increased for 3 consecutive years, from $6.63 in FY2022 to $11.14 in FY2025.
Based on SEC 10-K filings.
11.14 in FY2025 with a 5-year CAGR of +15.3%.
Improved from $7.22 to $11.14 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +18.9%
- 5-Year CAGR
- +15.3%
- 10-Year CAGR
- -
Sector benchmark
#87 of 210 in Health CareTop 41% of 210This company $11.14 Sector average $353.15
▼
-96.8% below sector average
Key checks
Key Insights
- Arrowhead Pharmaceuticals's assets per share has grown for 3 consecutive years.
- In FY2025, assets per share increased 4.9% year-over-year.
- Ranks #87 out of 210 companies in the Health Care sector.
- Lowest assets per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.14 | +4.9% |
| FY2024 | $10.62 | +47.0% |
| FY2023 | $7.22 | +8.9% |
| FY2022 | $6.63 | -4.4% |
| FY2021 | $6.94 | +26.8% |
| FY2020 | $5.47 | +38.4% |
| FY2019 | $3.95 | +164.9% |
| FY2018 | $1.49 | +0.1% |
| FY2017 | $1.49 | -30.7% |
| FY2016 | $2.15 | -11.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026